IgG1 From Human COVID-19 Convalescent Plasma

IgG1 From Human COVID-19 Convalescent Plasmais available at Gentaur for Next week Delivery.

Description: SARS-CoV-2 was initially identified in Wuhan City, Hubei Province, China, and has since resulted in a global pandemic. Medical, clinical, and scientific forces have collaborated to create innovative treatments that target the specific viral proteins and inhibit viral replication, as well as develop several viable vaccines against SARS-CoV-2. Among the treatments is injecting high-risk COVID-19 patients with convalescent plasma donated from other patients who have recovered from their own infection. This research-grade product comprises the isolated, purified, and enriched immunoglobulin isotype IgG1 pool from donated human COVID-19 convalescent plasma. Applications include serving as positive controls for testing kits; epitope mapping; and potential testing for new vaccines.

Immunogen Sequence:FAUX

Target Alternative Name:Severe acute respiratory syndrome coronavirus 2; COVID-19

Species Reactivities:SARS-CoV-2

Tag Line:Enriched IgG1 isolated from convalescent plasma donated by human SARS-CoV-2 patients

Formulation:Lyophilized from 20 mM phosphate buffer, pH 7.4, with 150 mM NaCl

Purification: Prepared from plasma shown to be non-reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.

Application:/

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use.